The key difference is cost: PlexusDx is $189/mo month-to-monthnth flat rate versus branded $900-1,200 monthly, making it accessible across all 50 states without insurance
Plaintiffs allege that side effects were not fully disclosed, impacting patient health when used as prescribed for diabetes management and weight loss
Drug interactions affecting tirzepatide levels are uncommon because the medication is not metabolized by cytochrome P450 enzymes, resulting in a low potential for CYP-mediated interactions
Ask your pharmacy to run a test claim, which shows what your insurance will cover before you commit to filling the prescription
The useful analytical framework is to ask: what is the net present value of revenues the innovator can defend after patent expiry, given realistic lifecycle management success rates, biosimilar/generic competition timelines, and payer formulary dynamics